| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.50B | 1.50B | 1.39B | 1.58B | 1.45B |
| Gross Profit | 558.07M | 511.00M | 483.30M | 486.80M | 461.60M |
| EBITDA | 295.88M | 278.20M | 260.40M | 233.30M | 230.40M |
| Net Income | 105.57M | 80.10M | 56.50M | -14.70M | 88.90M |
Balance Sheet | |||||
| Total Assets | 2.59B | 1.61B | 1.71B | 1.92B | 1.51B |
| Cash, Cash Equivalents and Short-Term Investments | 232.08M | 146.00M | 132.40M | 172.40M | 107.20M |
| Total Debt | 1.14B | 678.50M | 603.30M | 672.20M | 353.30M |
| Total Liabilities | 1.82B | 1.23B | 1.12B | 1.24B | 927.20M |
| Stockholders Equity | 722.76M | 346.10M | 558.10M | 616.50M | 553.00M |
Cash Flow | |||||
| Free Cash Flow | 198.38M | 68.10M | 92.90M | 62.60M | 97.40M |
| Operating Cash Flow | 231.15M | 95.80M | 123.90M | 96.40M | 128.60M |
| Investing Cash Flow | -580.33M | -61.30M | -20.30M | -319.30M | -30.00M |
| Financing Cash Flow | 435.75M | 3.60M | -147.00M | 295.00M | -57.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | £1.61B | 18.85 | 18.19% | 2.92% | 0.47% | -14.06% | |
70 Outperform | £15.27B | 17.45 | 52.86% | 1.80% | 9.74% | 0.92% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | £7.37B | 298.74 | 0.69% | 1.18% | 14.13% | -96.12% | |
55 Neutral | £4.08B | -40.23 | -2.99% | ― | -9.44% | -170.53% | |
52 Neutral | £257.99M | -0.84 | -111.93% | ― | -14.89% | 12.08% | |
41 Neutral | £267.98M | -3.32 | -9999.00% | ― | -65.42% | 27.73% |